BCRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.80%

Insider Buying (Last 12 Months): $596,337.56

Insider Selling (Last 12 Months): $82,486.00

BioCryst Pharmaceuticals Insider Trading History Chart

BioCryst Pharmaceuticals Share Price & Price History

^$7.91

▼ -0.01 (-0.13%)

As of 09/16/2024 01:00 AM ET

Days: 30 | 90 | 365

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

BioCryst Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/24/2024	Amy E Mckee	Director	Sell	8,600	$6.32	$54,352.00	27,831
6/17/2024	Machelle Sanders	Director	Sell	4,689	$6.00	$28,134.00	27,742
5/30/2024	Alan G Levin	Director	Buy	7,861	$6.36	$49,995.96	44,951
5/24/2024	Steve Aselage	Director	Buy	2,500	$6.40	$16,000.00	2,500
5/20/2024	Nancy J. Hutson	Director	Buy	5,000	$6.38	$31,900.00	86,818
5/14/2024	Anthony Doyle	CFO	Buy	36,300	$5.57	$202,191.00	266,744
5/14/2024	Helen M Thackray	Insider	Buy	30,000	$5.86	$175,800.00	272,139
5/13/2024	Steven K Galson	Director	Buy	21,940	$5.49	$120,450.60	51,551
6/15/2023	Machelle Sanders	Director	Sell	4,000	$7.98	$31,920.00	25,611
2/1/2023	Jon P. Stonehouse	CEO	Sell	100,000	$10.38	$1,038,000.00	1,008,739
12/15/2022	Anthony Doyle	CFO	Sell	5,700	$10.90	$62,130.00	163,966
12/15/2022	Helen M Thackray	Insider	Sell	3,125	$10.89	$34,031.25	133,275
12/15/2022	Jon P. Stonehouse	CEO	Sell	14,100	$10.90	$153,690.00	887,730
12/15/2022	Michael L Jones	Director	Sell	445	$10.90	$4,850.50	10,753
12/2/2022	Jon P. Stonehouse	CEO	Sell	82,656	$12.80	$1,057,996.80	901,830
12/1/2022	Michael L Jones	Director	Sell	8,600	$13.01	$111,886.00	11,198
11/14/2022	Yarlagadda S. Babu	Insider	Sell	31,515	$13.88	$437,428.20	298,541
4/1/2022	Helen M Thackray	Insider	Sell	7,600	$16.20	$123,120.00	136,400
2/15/2022	George B. Abercrombie	Director	Sell	5,000	$18.50	$92,500.00
1/11/2022	Jon P. Stonehouse	CEO	Sell	184,000	$15.04	$2,767,360.00
12/7/2021	Yarlagadda S. Babu	Insider	Sell	30,100	$12.20	$367,220.00
11/24/2021	Vincent Milano	Director	Buy	7,500	$12.19	$91,425.00
11/23/2021	Anthony Doyle	CFO	Buy	35,258	$12.48	$440,019.84
11/15/2021	George B. Abercrombie	Director	Sell	5,000	$12.27	$61,350.00
10/15/2021	Nancy J. Hutson	Director	Sell	105,000	$15.40	$1,617,000.00

How Boeing Disasters Could Impact Nvidia

From Stansberry Research | Ad

How The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart midflight and catching fire. But, according to analyst Dan Ferris, there's something much darker going on here that could threaten Nvidia, the Magnificent 7, and the entire U.S. stock market.

Click here for the full story.

SEC Filings (Institutional Ownership Changes) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

85.88% of BioCryst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioCryst Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/5/2024	Sanctuary Advisors LLC	26,571	$0.16M	0.0%	N/A	0.013%
8/16/2024	Northeast Financial Consultants Inc	65,633	$0.41M	0.0%	+8.2%	0.032%
8/16/2024	Creative Planning	46,613	$0.29M	0.0%	+75.2%	0.023%
8/16/2024	Algert Global LLC	353,133	$2.18M	0.1%	+18.6%	0.171%
8/15/2024	Susquehanna Fundamental Investments LLC	30,176	$0.19M	0.0%	-53.1%	0.015%
8/15/2024	Mackenzie Financial Corp	27,913	$0.17M	0.0%	-13.5%	0.014%
8/15/2024	The Manufacturers Life Insurance Company	212,581	$1.31M	0.0%	+113.8%	0.103%
8/15/2024	Millennium Management LLC	1,751,561	$10.83M	0.0%	-13.8%	0.849%
8/15/2024	Deerfield Management Company L.P. Series C	8,135,804	$50.28M	0.8%	+62.9%	3.942%
8/15/2024	AQR Capital Management LLC	543,241	$3.36M	0.0%	+18.8%	0.263%
8/15/2024	ELCO Management Co. LLC	30,792	$0.19M	0.1%	-14.5%	0.015%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	72,666	$0.45M	0.1%	N/A	0.035%
8/15/2024	Point72 Europe London LLP	267,649	$1.65M	0.1%	N/A	0.130%
8/14/2024	Cubist Systematic Strategies LLC	1,112,232	$6.87M	0.0%	+528.0%	0.538%
8/14/2024	Point72 DIFC Ltd	66,564	$0.41M	0.0%	+598.2%	0.032%
8/14/2024	Xponance Inc.	12,980	$80K	0.0%	+13.1%	0.006%
8/14/2024	Avoro Capital Advisors LLC	12,570,000	$77.68M	1.0%	-3.7%	6.091%
8/14/2024	DRW Securities LLC	11,987	$74K	0.0%	N/A	0.006%
8/14/2024	ProShare Advisors LLC	38,128	$0.24M	0.0%	-21.4%	0.018%
8/14/2024	Profund Advisors LLC	86,815	$0.54M	0.0%	-64.1%	0.042%
8/12/2024	Inspire Investing LLC	57,550	$0.36M	0.0%	-17.2%	0.028%
8/12/2024	XTX Topco Ltd	156,946	$0.97M	0.1%	+299.0%	0.076%
8/12/2024	Seven Eight Capital LP	169,612	$1.05M	0.1%	+1,407.1%	0.082%
8/12/2024	Hsbc Holdings PLC	125,004	$0.76M	0.0%	+32.7%	0.061%
8/12/2024	E Fund Management Co. Ltd.	28,285	$0.18M	0.0%	-61.9%	0.014%
8/9/2024	Renaissance Technologies LLC	960,180	$5.93M	0.0%	-39.6%	0.465%
8/8/2024	American Century Companies Inc.	148,490	$0.92M	0.0%	+896.6%	0.072%
8/8/2024	Rice Hall James & Associates LLC	2,079,641	$12.85M	0.8%	-3.3%	1.008%
8/7/2024	Headlands Technologies LLC	16,750	$0.10M	0.0%	N/A	0.008%
8/6/2024	Los Angeles Capital Management LLC	97,577	$0.60M	0.0%	+8.9%	0.047%
8/3/2024	TD Asset Management Inc	240,600	$1.49M	0.0%	N/A	0.117%
8/1/2024	Rhumbline Advisers	318,665	$1.97M	0.0%	+6.3%	0.154%
7/31/2024	nVerses Capital LLC	10,200	$63K	0.0%	N/A	0.005%
7/31/2024	Commonwealth Equity Services LLC	143,874	$0.89M	0.0%	-1.0%	0.070%
7/30/2024	Signaturefd LLC	6,598	$41K	0.0%	+560.5%	0.003%
7/29/2024	Principal Financial Group Inc.	35,524	$0.22M	0.0%	-26.3%	0.017%
7/29/2024	Panagora Asset Management Inc.	650,318	$4.02M	0.0%	+2.8%	0.315%
7/27/2024	Leisure Capital Management	28,000	$0.17M	0.1%	N/A	0.014%
7/26/2024	Bank of New York Mellon Corp	775,957	$4.80M	0.0%	+12.5%	0.376%
7/18/2024	Assenagon Asset Management S.A.	64,907	$0.40M	0.0%	-83.2%	0.031%
7/16/2024	Diversified Trust Co	24,752	$0.15M	0.0%	+18.0%	0.012%
7/10/2024	CWM LLC	5,658	$35K	0.0%	+200.0%	0.003%
5/17/2024	Tidal Investments LLC	55,560	$0.28M	0.0%	N/A	0.027%
5/16/2024	Redwood Investment Management LLC	122,270	$0.62M	0.1%	N/A	0.059%
5/16/2024	California State Teachers Retirement System	184,788	$0.94M	0.0%	-7.6%	0.090%
5/16/2024	Jacobs Levy Equity Management Inc.	156,119	$0.79M	0.0%	+62.0%	0.076%
5/16/2024	Kynam Capital Management LP	6,527,491	$33.16M	3.5%	+41.9%	3.163%
5/15/2024	Sarissa Capital Management LP	1,094,168	$5.56M	1.0%	+9.4%	0.530%
5/15/2024	Price T Rowe Associates Inc. MD	130,775	$0.67M	0.0%	+15.0%	0.063%
5/14/2024	Nan Fung Group Holdings Ltd	36,847	$0.19M	0.2%	+106.5%	0.018%
5/14/2024	EntryPoint Capital LLC	42,679	$0.22M	0.2%	+689.8%	0.021%
5/14/2024	Shell Asset Management Co.	21,854	$0.11M	0.0%	N/A	0.011%
5/14/2024	Natixis	11,684	$59K	0.0%	+400.6%	0.006%
5/13/2024	Seven Eight Capital LP	11,254	$57K	0.0%	N/A	0.005%
5/10/2024	Vanguard Group Inc.	17,676,767	$89.80M	0.0%	-0.5%	8.567%
5/8/2024	ProShare Advisors LLC	48,503	$0.25M	0.0%	+9.1%	0.024%
5/8/2024	Russell Investments Group Ltd.	58,725	$0.30M	0.0%	+200.8%	0.028%
5/8/2024	Inspire Investing LLC	69,466	$0.35M	0.0%	+9.7%	0.034%
5/7/2024	Susquehanna Fundamental Investments LLC	64,365	$0.33M	0.0%	N/A	0.031%
5/7/2024	Swiss National Bank	363,968	$1.85M	0.0%	-2.5%	0.176%
5/7/2024	SG Americas Securities LLC	13,548	$69K	0.0%	-79.5%	0.007%
5/2/2024	Mutual of America Capital Management LLC	212,781	$1.08M	0.0%	-4.0%	0.103%
5/1/2024	BNP Paribas Financial Markets	167,782	$0.85M	0.0%	-78.8%	0.081%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	138,074	$0.70M	0.0%	+13.0%	0.067%
4/30/2024	J.W. Cole Advisors Inc.	12,600	$64K	0.0%	-37.3%	0.006%
4/29/2024	China Universal Asset Management Co. Ltd.	39,639	$0.20M	0.0%	+67.3%	0.019%
4/24/2024	Assenagon Asset Management S.A.	386,885	$1.97M	0.0%	-26.9%	0.188%
4/23/2024	Rice Hall James & Associates LLC	2,151,545	$10.93M	0.6%	-2.1%	1.044%
4/5/2024	Los Angeles Capital Management LLC	89,614	$0.46M	0.0%	+68.0%	0.043%
3/11/2024	Vanguard Group Inc.	17,763,720	$106.41M	0.0%	+15.4%	8.617%
3/5/2024	Fisher Asset Management LLC	2,884,569	$17.28M	0.0%	-9.4%	1.399%
2/27/2024	Counterweight Ventures LLC	13,500	$81K	0.1%	N/A	0.007%
2/20/2024	Quarry LP	9,000	$54K	0.0%	N/A	0.004%
2/14/2024	Oracle Investment Management Inc.	535,558	$3.21M	2.0%	-3.6%	0.261%
2/14/2024	Braidwell LP	5,718,477	$34.25M	1.3%	+6.6%	2.792%
2/14/2024	Avoro Capital Advisors LLC	13,050,000	$78.17M	1.1%	+13.0%	6.372%
2/14/2024	Kynam Capital Management LP	4,600,000	$27.55M	3.1%	+46.8%	2.246%
2/13/2024	Tower Research Capital LLC TRC	10,420	$62K	0.0%	+131.1%	0.005%
2/13/2024	Rafferty Asset Management LLC	955,587	$5.72M	0.0%	+18.3%	0.467%
2/12/2024	Capstone Investment Advisors LLC	18,650	$0.11M	0.0%	N/A	0.009%
2/9/2024	Aigen Investment Management LP	12,670	$76K	0.0%	-91.7%	0.006%
2/9/2024	GW&K Investment Management LLC	2,337,683	$14M	0.1%	-9.1%	1.141%
2/9/2024	Trexquant Investment LP	421,516	$2.53M	0.1%	-28.9%	0.206%
2/9/2024	Norges Bank	2,216,612	$13.28M	0.0%	N/A	1.082%
2/8/2024	Panagora Asset Management Inc.	669,067	$4.01M	0.0%	-8.0%	0.327%
2/8/2024	Pinnacle Wealth Planning Services Inc.	20,561	$0.12M	0.0%	N/A	0.010%
2/7/2024	Jump Financial LLC	128,771	$0.77M	0.0%	-68.2%	0.063%
2/7/2024	BNP Paribas Financial Markets	790,163	$4.73M	0.0%	+45.5%	0.386%
2/7/2024	Teacher Retirement System of Texas	43,827	$0.26M	0.0%	-18.3%	0.021%
2/7/2024	E Fund Management Co. Ltd.	51,317	$0.31M	0.0%	+23.7%	0.025%
2/6/2024	Charles Schwab Investment Management Inc.	1,594,436	$9.55M	0.0%	+9.1%	0.778%
2/6/2024	Amalgamated Bank	24,257	$0.15M	0.0%	-7.2%	0.012%
2/6/2024	Los Angeles Capital Management LLC	53,330	$0.32M	0.0%	+61.0%	0.026%
2/6/2024	Swiss National Bank	373,468	$2.24M	0.0%	-10.1%	0.182%
2/6/2024	Fisher Asset Management LLC	2,884,097	$17.28M	0.0%	-9.5%	1.408%
2/5/2024	Victory Capital Management Inc.	26,842	$0.16M	0.0%	+31.5%	0.013%
2/1/2024	New York State Common Retirement Fund	59,075	$0.35M	0.0%	-23.2%	0.029%
2/1/2024	Handelsbanken Fonder AB	45,900	$0.28M	0.0%	+29.3%	0.022%
1/31/2024	abrdn plc	504,528	$3.02M	0.0%	N/A	0.246%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	47,359	$0.28M	0.0%	+27.1%	0.023%

Data available starting January 2016

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

Today's Range

Now: $7.91

$7.79

$8.05

50 Day Range

MA: $7.66

$6.42

$8.69

52 Week Range

Now: $7.91

$4.03

$8.88

Volume

1,850,193 shs

Average Volume

3,165,400 shs

Market Capitalization

$1.63 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Who are the company insiders with the largest holdings of BioCryst Pharmaceuticals?: BioCryst Pharmaceuticals' top insider shareholders include:
Jon P Stonehouse (CEO)
Yarlagadda S Babu (Insider)
Helen M Thackray (Insider)
Anthony Doyle (CFO)
Nancy J Hutson (Director)
Steven K Galson (Director)
Alan G Levin (Director)
Amy E Mckee (Director)
Machelle Sanders (Director)
Michael L Jones (Director)
Steve Aselage (Director)
Learn More about top insider investors at BioCryst Pharmaceuticals.
Who are the major institutional investors of BioCryst Pharmaceuticals?: BioCryst Pharmaceuticals' top institutional shareholders include:
Avoro Capital Advisors LLC — 6.09%
Deerfield Management Company L.P. Series C — 3.94%
Rice Hall James & Associates LLC — 1.01%
Millennium Management LLC — 0.85%
Cubist Systematic Strategies LLC — 0.54%
Renaissance Technologies LLC — 0.47%
Learn More about top institutional investors of BioCryst Pharmaceuticals stock.
Which major investors are selling BioCryst Pharmaceuticals stock?: During the last quarter, BCRX stock was sold by these institutional investors:
Renaissance Technologies LLC
Avoro Capital Advisors LLC
Assenagon Asset Management S.A.
Millennium Management LLC
Profund Advisors LLC
Rice Hall James & Associates LLC
E Fund Management Co. Ltd.
Susquehanna Fundamental Investments LLC
Within the previous year, company insiders that have sold BioCryst Pharmaceuticals company stock include:
Jon P Stonehouse (CEO)
Yarlagadda S Babu (Insider)
Learn More investors selling BioCryst Pharmaceuticals stock.
Which major investors are buying BioCryst Pharmaceuticals stock?: Within the previous quarter, BCRX stock was bought by institutional investors including:
Deerfield Management Company L.P. Series C
Cubist Systematic Strategies LLC
Point72 Europe London LLP
TD Asset Management Inc
Seven Eight Capital LP
American Century Companies Inc.
XTX Topco Ltd
The Manufacturers Life Insurance Company
In the previous year, these company insiders have bought BioCryst Pharmaceuticals stock:
Jon P Stonehouse (CEO)
Yarlagadda S Babu (Insider)
Helen M Thackray (Insider)
Anthony Doyle (CFO)
Nancy J Hutson (Director)
Steven K Galson (Director)
Learn More investors buying BioCryst Pharmaceuticals stock.